Industry News
Pharmaceutical Industry News
AbbVie’s Rinvoq, Pfizer’s Xeljanz win new uses after extended reviews as JAK safety woes linger
AbbVie's Rinvoq, Pfizer's Xeljanz win new uses after extended reviews as JAK safety woes linger aliu Wed, 12/15/2021 - 09:46
Sayonara, San Francisco. #JPM22 is going virtual, thanks to COVID
Sayonara, San Francisco. #JPM22 is going virtual, thanks to COVID esagonowsky Wed, 12/15/2021 - 09:38
Abbott’s research initiative finds gap between perceived and actual patient experience in vascular care
Abbott's research initiative finds gap between perceived and actual patient experience in vascular care sharon.coey Wed, 12/15/2021 - 05:17
Pfizer’s Covid Pill Works Well, Company Confirms in Final Analysis
The treatment, called Paxlovid, is likely to work against Omicron and could be available in the United States before the end of the year.
Senators Question Califf, the F.D.A. Nominee, on Opioid Crisis and Pandemic Response
A Senate panel hearing on Tuesday signaled that Dr. Robert Califf, who briefly led the agency during the Obama administration, had some bipartisan support.
For the first time, England’s NICE blesses PrEP drugs to prevent HIV
For the first time, England's NICE blesses PrEP drugs to prevent HIV kdunleavy Tue, 12/14/2021 - 14:54
Aerami Therapeutics, eager to breeze into smart inhaler market, unveils $250M SPAC deal
Aerami Therapeutics, eager to breeze into smart inhaler market, unveils $250M SPAC deal fkansteiner Tue, 12/14/2021 - 13:23
Can Eye Drops Replace Reading Glasses?
Vuity, a once-a-day treatment that can help users see up close without affecting their long-range vision, went on the market Thursday after being approved by the F.D.A. in October.
Texas launches investigation of AbbVie, Endo for alleged off-label promotion of puberty blocking drugs
Texas launches investigation of AbbVie, Endo for alleged off-label promotion of puberty blocking drugs kdunleavy Tue, 12/14/2021 - 11:20
Lannett to shutter Silarx liquid drug manufacturing facility in New York, lay off 72 workers
Lannett to shutter Silarx liquid drug manufacturing facility in New York, lay off 72 workers jkeenan Tue, 12/14/2021 - 11:00
Fujifilm beefs up US biologics capacity with $300M Texas outlay, corrals 150 new jobs
Fujifilm beefs up US biologics capacity with $300M Texas outlay, corrals 150 new jobs fkansteiner Tue, 12/14/2021 - 10:20
CSL to buy Vifor for $11.7B in biopharma’s largest M&A deal this year
CSL to buy Vifor for $11.7B in biopharma's largest M&A deal this year kdunleavy Tue, 12/14/2021 - 09:37
Samsung Biologics, AstraZeneca expand manufacturing partnership to add COVID and cancer therapies
Samsung Biologics, AstraZeneca expand manufacturing partnership to add COVID and cancer therapies jkeenan Tue, 12/14/2021 - 08:42
Pfizer Says Its Covid Pill, Paxlovid, Will Protect Against Severe Disease
The company said the pill, Paxlovid, reduced the risk of hospitalization and death by 89 percent if given within three days of the onset of symptoms.
Firms Push for Over-the-Counter Access to Birth-Control Pills
Two drugmakers have been mired for years in the pre-application phase of getting F.D.A. approval for over-the-counter use.
Idorsia hoping to make its dreams come true with a new insomnia alliance
Idorsia hoping to make its dreams come true with a new insomnia alliance badams Tue, 12/14/2021 - 04:28
CanSino taps Aerogen for development, commercial supply of inhaled COVID-19 vaccine hopeful
CanSino taps Aerogen for development, commercial supply of inhaled COVID-19 vaccine hopeful fkansteiner Mon, 12/13/2021 - 16:00
Viatris gets shot to shed infringement claims in long-running patent kerfuffle on AstraZeneca’s Symbicort
Viatris gets shot to shed infringement claims in long-running patent kerfuffle on AstraZeneca's Symbicort fkansteiner Mon, 12/13/2021 - 13:18
Novo Nordisk, underway with key launches, reveals $2.58B manufacturing investment
Novo Nordisk, underway with key launches, reveals $2.58B manufacturing investment kdunleavy Mon, 12/13/2021 - 11:20
Bristol Myers Squibb, after massive Celgene takeover, plots $15B buyback plan
Bristol Myers Squibb, after massive Celgene takeover, plots $15B buyback plan fkansteiner Mon, 12/13/2021 - 10:55